MOVE vs MNMD vs AEYE vs BWAY vs GRMN

For growth investors, BrainsWay Ltd.

(BWAY) is the stronger pick with 28. 3% revenue growth year-over-year, versus 14. 5% for AudioEye, Inc. (AEYE). Garmin Ltd. (GRMN) offers the better valuation at 27. 3x trailing P/E (24. 7x forward), making it the more compelling value choice. Analysts rate Movano Inc. (MOVE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Garmin Ltd.

(GRMN) is the cheapest at 27. 3x versus BrainsWay Ltd. at 45. 6x. On forward P/E, Garmin Ltd. is actually cheaper at 24. 7x.

Over the past 5 years, BrainsWay Ltd.

(BWAY) delivered a total return of +291. 0%, compared to -98. 3% for Movano Inc. (MOVE). Over 10 years, the gap is even starker: GRMN returned +534. 9% versus MOVE's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Garmin Ltd.

(GRMN) is the lower-risk stock at 1. 30β versus AudioEye, Inc. 's 2. 29β — meaning AEYE is approximately 76% more volatile than GRMN relative to the S&P 500. On balance sheet safety, Garmin Ltd. (GRMN) carries a lower debt/equity ratio of 2% versus 15% for AudioEye, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), BrainsWay Ltd.

(BWAY) is pulling ahead at 28. 3% versus 14. 5% for AudioEye, Inc. (AEYE). On earnings-per-share growth, the picture is similar: BrainsWay Ltd. grew EPS 300. 0% year-over-year, compared to -1273. 3% for Mind Medicine (MindMed) Inc.. Over a 3-year CAGR, BWAY leads at 24. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Garmin Ltd.

(GRMN) is the more profitable company, earning 23. 0% net margin versus -23. 4% for Movano Inc. — meaning it keeps 23. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GRMN leads at 25. 9% versus -23. 9% for MOVE. At the gross margin level — before operating expenses — AEYE leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Garmin Ltd.

(GRMN) trades at 24. 7x forward P/E versus 84. 2x for BrainsWay Ltd. — 59. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GRMN: 14. 6% to $269. 00.

In this comparison, GRMN (1.

5% yield) pays a dividend. MOVE, MNMD, AEYE, BWAY do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Garmin Ltd.

(GRMN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 5% yield, +534. 9% 10Y return). Movano Inc. (MOVE) carries a higher beta of 1. 98 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GRMN: +534. 9%, MOVE: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MOVE (Healthcare) and MNMD (Healthcare) and AEYE (Technology) and BWAY (Healthcare) and GRMN (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MOVE is a small-cap quality compounder stock; MNMD is a small-cap quality compounder stock; AEYE is a small-cap quality compounder stock; BWAY is a small-cap high-growth stock; GRMN is a mid-cap high-growth stock. GRMN pays a dividend while MOVE, MNMD, AEYE, BWAY do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.